Talphera (TLPH) Total Non-Current Liabilities (2010 - 2026)

Talphera's (TLPH) quarterly Total Non-Current Liabilities came in at $10.5 million in Q1 2026, up 23.58% year-on-year from $8.5 million in Q1 2025, and up 2.1% quarter-over-quarter from $10.3 million in Q4 2025.

Talphera (TLPH) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Talphera's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $10.5 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 23.58% year-over-year to $10.5 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 23.58% increase from a year earlier, with the FY2025 full-year figure at $10.3 million, up 12.36% from the prior year.
  • Total Non-Current Liabilities improved to $10.5 million in Q1 2026 per TLPH's latest filing, from $10.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $25.6 million in Q1 2022 and bottomed at $4.5 million in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $9.7 million (2025), against an average of $11.8 million.
  • Across the five-year window, Total Non-Current Liabilities tumbled 81.97% in 2022 and surged 103.32% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $18.6 million in 2022, then slumped by 75.71% to $4.5 million in 2023, then jumped by 103.32% to $9.2 million in 2024, then climbed by 12.36% to $10.3 million in 2025, then advanced by 2.1% to $10.5 million in 2026.
  • Per Business Quant, the three latest TLPH Total Non-Current Liabilities figures stand at $10.5 million (Q1 2026), $10.3 million (Q4 2025), and $9.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Talphera 47.31 Mn 9.48 Mn - 10.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.52 Mn
Dec 31, 2025 10.31 Mn
Sep 30, 2025 9.71 Mn
Jun 30, 2025 9.13 Mn
Mar 31, 2025 8.52 Mn
Dec 31, 2024 9.17 Mn
Sep 30, 2024 9.29 Mn
Jun 30, 2024 9.80 Mn
Mar 31, 2024 9.66 Mn
Dec 31, 2023 4.51 Mn
Sep 30, 2023 4.95 Mn
Jun 30, 2023 7.31 Mn
Mar 31, 2023 10.26 Mn
Dec 31, 2022 18.58 Mn
Sep 30, 2022 20.77 Mn
Jun 30, 2022 22.99 Mn
Mar 31, 2022 25.63 Mn
Dec 31, 2021 28.50 Mn
Sep 30, 2021 115.18 Mn
Jun 30, 2021 115.45 Mn